HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors (original) (raw)
McMichael, A.J. & Rowland-Jones, S.L. Cellular immune responses to HIV. Nature410, 980–987 (2001). ArticleCASPubMed Google Scholar
Lieberman, J., Shankar, P., Manjunath, N. & Andersson, J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood98, 1667–1677 (2001). ArticleCASPubMed Google Scholar
Goulder, P.J. et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res. Hum. Retroviruses12, 1691–1698 (1996). ArticleCASPubMed Google Scholar
Kaslow, R.A. et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med.2, 405–411 (1996). ArticleCASPubMed Google Scholar
Carrington, M. et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science283, 1748–1752 (1999). ArticleCASPubMed Google Scholar
Flores-Villanueva, P.O. et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA98, 5140–5145 (2001). ArticleCASPubMedPubMed Central Google Scholar
Migueles, S.A. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA.97, 2709–2714 (2000). ArticleCASPubMedPubMed Central Google Scholar
Migueles, S.A. & Connors, M. Frequency and function of HIV-specific CD8+ T cells. Immunol. Lett.79, 141–150 (2001). ArticleCASPubMed Google Scholar
Gea-Banacloche, J.C. et al. Maintenance of large numbers of virus specific CD8+ T cells in HIV infected progressors and long term nonprogressors. J. Immunol.165, 1082–1092 (2000). ArticleCASPubMed Google Scholar
Dalod, M. et al. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8+ responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol.73, 7108–7116 (1999). CASPubMedPubMed Central Google Scholar
Betts, M.R. et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses: relationship to viral load in untreated HIV infection. J. Virol.75, 11983–11991 (2001). ArticleCASPubMedPubMed Central Google Scholar
Kostense, S. et al. Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-γ+ HIV-specific T cells during progression to AIDS. Blood99, 2505–2511 (2002). ArticleCASPubMed Google Scholar
Pantaleo, G. et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med.332, 209–216 (1995). ArticleCASPubMed Google Scholar
Strathdee, S.A. et al. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS10, 959–965 (1996). ArticleCASPubMed Google Scholar
Oxenius, A. et al. Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8–18 months of antiretroviral therapy in acutely infected patients. AIDS15, 1653–1656 (2001). ArticleCASPubMed Google Scholar
Gray, C.M. et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol.162, 1780–1788 (1999). CASPubMed Google Scholar
Ogg, G.S. et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol.73, 797–800 (1999). CASPubMedPubMed Central Google Scholar
Ferrari, G. et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA94, 1396–1401 (1997). ArticleCASPubMedPubMed Central Google Scholar
Shankar, P., Xu, Z. & Lieberman, J. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood94, 3084–3093 (1999). CASPubMed Google Scholar
Champagne, P. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature410, 106–111 (2001). ArticleCASPubMed Google Scholar
Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Med.8, 379–385 (2002). ArticleCASPubMed Google Scholar
Sandberg, J.K., Fast, N.M. & Nixon, D.F. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J. Immunol.167, 181–187 (2001). ArticleCASPubMed Google Scholar
Faint, J.M. et al. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J. Immunol.167, 212–220. (2001). ArticleCASPubMed Google Scholar
Andersson, J. et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS13, 1295–1303 (1999). ArticleCASPubMed Google Scholar
Lopez Bernaldo de Quiros, J.C. et al. Resistance to replication of HIV challenge virus in SCID-Hu mice engrafted with PBMC of nonprogressors is mediated by CD8+ T cells and associated with a proliferative response to p24 antigen. J. Virol.74, 2023–2028 (2000). Article Google Scholar
Goulder, P.J. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med.3, 212–217 (1997). ArticleCASPubMed Google Scholar
Goulder, P.J. et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature412, 334–338 (2001). ArticleCASPubMed Google Scholar
Kelleher, A.D. et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med.193, 375–386 (2001). ArticleCASPubMedPubMed Central Google Scholar
Bachmann, M.F., Barner, M., Viola, A. & Kopf, M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur. J. Immunol.29, 291–299 (1999). ArticleCASPubMed Google Scholar
Slifka, M.K., Rodriguez, F. & Whitton, J.L. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature401, 76–79 (1999). ArticleCASPubMed Google Scholar
Goulder, P.J. et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med.193, 181–194 (2001). ArticleCASPubMedPubMed Central Google Scholar
Kaslow, R.A. et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J. Virol.75, 8681–8689 (2001). ArticleCASPubMedPubMed Central Google Scholar
Liu, Z. et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.18, 332–340 (1998). ArticleCASPubMed Google Scholar
Sieg, S.F., Mitchem, J.B., Bazdar, D.A. & Lederman, M.M. Close link between CD4+ and CD8+ T cell proliferation defects in patients with human immunodeficiency virus disease and relationship to extended periods of CD4+ lymphopenia. J. Infect. Dis.185, 1401–1416 (2002). ArticlePubMed Google Scholar
Lewis, D.E., NgTang, D.S., Adu-Oppong, A., Schober, W. & Rodgers, J.R. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol.153, 412–420 (1994). CASPubMed Google Scholar
Mueller, Y.M. et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells. Immunity15, 871–882 (2001). ArticleCASPubMed Google Scholar
Cannavo, G. et al. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis. Blood97, 1756–1764 (2001). ArticleCASPubMed Google Scholar
Paiardini, M. et al. Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals. J. Virol.75, 10843–10855 (2001). ArticleCASPubMedPubMed Central Google Scholar
Pantaleo, G., Koenig, S., Baseler, M., Lane, H.C. & Fauci, A.S. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. J. Immunol.144, 1696–1704 (1990). CASPubMed Google Scholar
Andersson, J. et al. Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J. Infect. Dis.185, 1355–1358 (2002). ArticleCASPubMed Google Scholar
Kaech, S.M., Wherry, J. & Ahmed, R. Effector and memory T-cell differentiation: Implications for vaccine development. Nature Rev. Immunol.2, 251–262 (2002). ArticleCAS Google Scholar
Imami, N. et al. Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. Immunol. Lett.79, 63–76 (2001). ArticleCASPubMed Google Scholar
Lloyd, T.E. et al. Regulation of CD28 costimulation in human CD8+ T cells. J. Immunol.158, 1551–1558 (1997). CASPubMed Google Scholar
Otten, G.R. & Germain, R.N. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science251, 1228–1231 (1991). ArticleCASPubMed Google Scholar
Hanke, T. & McMichael, A.J. The quest for an AIDS vaccine: Is the CD8+ T cell approach feasible? Nature Rev. Immunol.2, 283–291 (2002). Article Google Scholar
Cohen, O.J. et al. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Δ32. J. Virol.72, 6215–6217 (1998). CASPubMedPubMed Central Google Scholar
Holmes, K., Fowlkes, B., Schmid, I. & Giorgi, J. in Current Protocols in Immunology Vol. 1 (eds. Coligan, J., Kruisbeek, A., Margulies, D., Sheevac, E. & Strober, W.) 5.3.1–5.3.23 (Green Publishing, New York, 1995). Google Scholar
Toba, K., Winton, E.F., Koike, T. & Shibata, A. Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin D and pyronin Y. J. Immunol. Methods182, 193–207 (1995). ArticleCASPubMed Google Scholar